⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21141113 | 0.69 | — | — | |
| SCHEMBL18071832 | 0.64 | — | — | |
| SCHEMBL18931620 | 0.60 | — | — | |
| SCHEMBL17466029 | 0.60 | — | — | |
| SCHEMBL1045321 | 0.58 | — | — | |
| SCHEMBL2562820 | 0.52 | — | — | |
| SCHEMBL5354 | 0.52 | — | — | |
| SCHEMBL23174590 | 0.52 | — | — | |
| Lithium Ion SCHEMBL7345359 | 0.52 | — | — | |
| SCHEMBL20212036 | 0.51 | ALDH1A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1373252-A1 | CHEMICAL DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT | Aventis Pharma S.A. (FR) | 2004-01-02 | — | — | EP | disclosed |
| WO-2002076975-A1 | CHEMICAL DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT | AVENTIS PHARMA S.A. (FR) | 2002-10-03 | — | — | WO | disclosed |